Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vericel Corporation
(NQ:
VCEL
)
54.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vericel Corporation
< Previous
1
2
3
4
5
Next >
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Vericel Reports Third Quarter 2024 Financial Results
November 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Earnings Preview For Vericel
November 06, 2024
Via
Benzinga
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
August 27, 2024
Via
Benzinga
Expert Ratings For Vericel
August 09, 2024
Via
Benzinga
The Latest Analyst Ratings For Vericel
August 02, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts
July 16, 2024
Via
Benzinga
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
August 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
August 26, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Critical Insights From Vericel Analyst Ratings: What You Need To Know
May 09, 2024
Via
Benzinga
Analyst Scoreboard: 5 Ratings For Vericel
March 26, 2024
Via
Benzinga
Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday
August 02, 2024
Via
Benzinga
Vericel Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
July 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
From
Vericel Corporation
Via
GlobeNewswire
A Closer Look at 4 Analyst Recommendations For Vericel
March 01, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
The 3 Highest-Rated Medical Stocks You Can Buy Today
June 27, 2024
Are you looking for highly-rated medical stocks? These three contenders are offering substantial growth over the long term.
Via
InvestorPlace
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
June 11, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
May 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
VCEL stock results show that Vericel beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
May 08, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
February 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
February 27, 2024
From
Vericel Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.